Altimmune ALT
NASDAQ ALT
$2.73 -0.03 (-1.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Altimmune (ALT) Return on Sales [ROS] (2010 - 2025)

Updated

Altimmune's Return on Sales [ROS] was -111126.92% in Q4 2025, up 386193.08 percentage points from -497320.00% a year earlier and up 306053.08 percentage points from the prior quarter.

Analysis

Altimmune (ALT) Return on Sales [ROS] (2010 - 2025) Analysis & Trends

For FY2025, Return on Sales [ROS] at Altimmune came in at -230460.98%, up 285399.02 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of -229791.48 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -515860.00% in FY2024 (-493341.46 pp), -22518.54% in FY2023 (+106510.87 pp), -129029.41% in FY2022 (-126831.82 pp) and -2197.60% in FY2021 (-1528.10 pp).
  • The Q4 2025 figure marks the highest quarterly Return on Sales [ROS] since Q4 2023.
  • Compared with a year earlier, Return on Sales [ROS] has increased for four straight quarters, with an average year-over-year change of -115277.06 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q3 2023 (a gain of 1231373.48 percentage points); the worst was Q3 2022 (a drop of 1216584.81 percentage points).
  • Per Business Quant data, ALT's Return on Sales [ROS] in the three quarters before Q4 2025 was -417180.00% (Q3 2025), -458440.00% (Q2 2025) and -436300.00% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Altimmune 530.91 Mn 530.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -111,126.92%
Sep 30, 2025 -417,180.00%
Jun 30, 2025 -458,440.00%
Mar 31, 2025 -436,300.00%
Dec 31, 2024 -497,320.00%
Sep 30, 2024 -495,340.00%
Jun 30, 2024 -534,900.00%
Mar 31, 2024 -535,880.00%
Dec 31, 2023 -90,872.97%
Sep 30, 2023 -6,226.52%
Jun 30, 2023 -300,116.67%
Mar 31, 2023 -103,614.29%
Dec 31, 2022 -88,823.08%
Sep 30, 2022 -1,237,600.00%
Jun 30, 2022 -254,937.50%
Mar 31, 2022 -60,934.38%
Dec 31, 2021 -731.92%
Sep 30, 2021 -21,015.19%
Jun 30, 2021 -18,148.91%
Mar 31, 2021 -1,773.39%
API Access

Altimmune Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ALT&period=max&api_key=YOUR_API_KEY